July 12 (Reuters) - Jazz Pharmaceuticals Plc
* Tender offer is being effected by Jazz Pharmaceuticals’ indirect wholly-owned subsidiary, Plex Merger Sub
* Condition to tender offer that majority of Celator’s outstanding shares be validly tendered has now been satisfied
* Announced results of its tender offer to purchase all of outstanding shares of common stock of Celator Pharmaceuticals Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)
Our Standards: The Thomson Reuters Trust Principles.